Hereditary hepatic fibrinogen storage disease with a novel fibrinogen variant FGG c.1113T>A ( fibrinogen Seoul III ).

IF 1.1
Kyong Eun Choi, Seon Young Kim, Hansol Kim, Yoon Zi Kim, Sang Yun Ha, Yon Ho Choe, Boram Kim, Hee-Jin Kim, Mi Jin Kim
{"title":"Hereditary hepatic fibrinogen storage disease with a novel fibrinogen variant FGG c.1113T>A ( fibrinogen Seoul III ).","authors":"Kyong Eun Choi, Seon Young Kim, Hansol Kim, Yoon Zi Kim, Sang Yun Ha, Yon Ho Choe, Boram Kim, Hee-Jin Kim, Mi Jin Kim","doi":"10.1097/MBC.0000000000001358","DOIUrl":null,"url":null,"abstract":"<p><p>Hereditary hepatic fibrinogen storage disease (HHFS) is an extremely rare genetic disorder caused by mutations in the fibrinogen gamma ( FGG ) gene. Clinical presentations range from asymptomatic cases to severe symptoms. We present the case of a 9-year-old boy with persistently elevated liver enzymes who exhibited no clinical symptoms. A liver biopsy revealed hepatic fibrinogen storage disease, and genetic testing identified a heterozygous mutation, c.1113T>A, p.(Asn371Lys) in FGG . This is the first reported case of HHFS in Korea, as well as the first report of this novel mutation. Multigene panel testing played a crucial role in diagnosing this rare condition. Following three months of ursodeoxycholic acid medication, liver enzyme levels normalized, and the patient is currently under follow-up.</p>","PeriodicalId":520571,"journal":{"name":"Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis","volume":" ","pages":"204-207"},"PeriodicalIF":1.1000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/MBC.0000000000001358","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/12 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Hereditary hepatic fibrinogen storage disease (HHFS) is an extremely rare genetic disorder caused by mutations in the fibrinogen gamma ( FGG ) gene. Clinical presentations range from asymptomatic cases to severe symptoms. We present the case of a 9-year-old boy with persistently elevated liver enzymes who exhibited no clinical symptoms. A liver biopsy revealed hepatic fibrinogen storage disease, and genetic testing identified a heterozygous mutation, c.1113T>A, p.(Asn371Lys) in FGG . This is the first reported case of HHFS in Korea, as well as the first report of this novel mutation. Multigene panel testing played a crucial role in diagnosing this rare condition. Following three months of ursodeoxycholic acid medication, liver enzyme levels normalized, and the patient is currently under follow-up.

遗传性肝纤维蛋白原储存病伴新型纤维蛋白原变异FGG c.1113T> a(纤维蛋白原Seoul III)。
遗传性肝纤维蛋白原贮存病(HHFS)是由纤维蛋白原γ (FGG)基因突变引起的一种极为罕见的遗传性疾病。临床表现从无症状病例到严重症状不等。我们提出的情况下,9岁男孩持续升高的肝酶谁表现出无临床症状。肝活检显示肝纤维蛋白原储存病,基因检测发现FGG中存在杂合突变,c.1113T>A, p.(Asn371Lys)。这是韩国报道的首例HHFS病例,也是首次报道这种新型突变。多基因面板测试在诊断这种罕见疾病中发挥了至关重要的作用。熊去氧胆酸治疗3个月后,肝酶水平恢复正常,目前正在随访中。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信